دورية أكاديمية
أعرض في EDS

Quality improvement project to enhance heparin safety in patients with haemodialysis in China.

التفاصيل البيبلوغرافية
العنوان: Quality improvement project to enhance heparin safety in patients with haemodialysis in China.
المؤلفون: Tan QZ; Department of Medicine, Division of Nephrology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Mai YF; Department of Medicine, Division of Nephrology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Jiao HH; Department of Medicine, Division of Nephrology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Xiong RJ; Department of Medicine, Division of Nephrology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Liu Y; Department of Medicine, Division of Nephrology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Lin L; Clinical Service Department, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Cui LW; Department of Medicine, Division of Nephrology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Pai P; Department of Medicine, Division of Nephrology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China ppai1@hku.hk.; Department of Medicine, Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
المصدر: BMJ open quality [BMJ Open Qual] 2022 Apr; Vol. 11 (2).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101710381 Publication Model: Print Cited Medium: Internet ISSN: 2399-6641 (Electronic) Linking ISSN: 23996641 NLM ISO Abbreviation: BMJ Open Qual Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : BMJ Publishing Group
مواضيع طبية MeSH: Heparin*/adverse effects , Quality Improvement*, Anticoagulants/adverse effects ; China ; Humans ; Renal Dialysis
مستخلص: Competing Interests: Competing interests: None declared.
References: Kidney Dis (Basel). 2016 Jun;2(2):88-94. (PMID: 27536697)
Semin Dial. 2015 Sep-Oct;28(5):474-89. (PMID: 25913603)
Qual Saf Health Care. 2006 Apr;15(2):89-91. (PMID: 16585106)
J Adv Nurs. 2022 Jan;78(1):224-238. (PMID: 34632614)
Eur J Hosp Pharm. 2020 Nov;27(6):e101. (PMID: 32859653)
Chin Med J (Engl). 2014;127(16):2881-7. (PMID: 25131221)
Jt Comm J Qual Patient Saf. 2010 May;36(5):195-202. (PMID: 20480751)
Clin J Am Soc Nephrol. 2015 Apr 7;10(4):688-95. (PMID: 25376767)
BMJ Qual Saf. 2012 May;21(5):361-8. (PMID: 22389018)
BMC Nephrol. 2017 Jun 7;18(1):187. (PMID: 28592259)
BMJ Qual Saf. 2014 Jul;23(7):556-64. (PMID: 24351971)
BMC Nephrol. 2019 Oct 17;20(1):379. (PMID: 31623578)
فهرسة مساهمة: Keywords: Incident reporting; Medication safety; Patient safety; Quality improvement; Root cause analysis
المشرفين على المادة: 0 (Anticoagulants)
9005-49-6 (Heparin)
تواريخ الأحداث: Date Created: 20220408 Date Completed: 20220411 Latest Revision: 20220625
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC8996018
DOI: 10.1136/bmjoq-2021-001665
PMID: 35393293
قاعدة البيانات: MEDLINE
الوصف
تدمد:2399-6641
DOI:10.1136/bmjoq-2021-001665